RIVERHEAD CAPITAL MANAGEMENT LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 148 filers reported holding CYTOKINETICS INC in Q3 2019. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2019$131,000
+1.6%
11,5000.0%0.01%0.0%
Q2 2019$129,000
+38.7%
11,5000.0%0.01%
+25.0%
Q1 2019$93,000
+89.8%
11,500
+49.4%
0.00%
+100.0%
Q4 2018$49,000
+2.1%
7,700
+57.1%
0.00%0.0%
Q3 2018$48,000
+118.2%
4,900
+88.5%
0.00%
+100.0%
Q2 2018$22,0002,6000.00%
Other shareholders
CYTOKINETICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders